MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0135372

Медицинская библиотека · PloS one · 2015

Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis.

Tan Shuai, Xiao Xiaojuan, Ma Hanyu, Zhang Zhaohui, Chen Jiangbo, Ding Lei, Yu Shenping, Xu Rulin, Yang Shiliang, Huang Xinyi, Hong Hua

Сравнительное исследованиеСтатьяМетаанализПоддержка исследования: вне правительства СШАОбзорПеревод пока не подготовлен

Аннотация

BACKGROUND AND PURPOSE: Antiplatelet therapy is widely used for the primary or secondary prevention of stroke. Drugs like clopidogrel have emerged as alternatives for traditional antiplatelet therapy, and dual therapy with clopidogrel and aspirin is of particular interest. We conducted this meta-analysis to systematically review studies about dual therapy comparing monotherapy with aspirin alone.

METHODS

Randomized controlled trials were searched in PubMed (1966-May, 2015), EMBASE (1947-May, 2015), the Cochrane Central Register of Controlled Trials (CENTRAL) (1948-May, 2015), WHO International Clinical Trial (ICTRP) (2004-May, 2015), China Biology Medicine disc (CBM disc) (1978-May, 2015) and were included into the final analysis according to the definite inclusion criteria mentioned in the study selection section. Risk ratio (RR) was pooled with 95% confidence interval (CI) for dichotomous data. The heterogeneity was considered significant if the χ2 test was significant (P value < 0.10) or the I2 > 50.00%. Subgroup analyses were carried out on the long and short time periods, the race and region.

RESULTS

We included 5 studies involving 24,084 patients. A pooled analysis showed that dual therapy with clopidogrel and aspirin had a lower stroke incidence than monotherapy in both the short term and long term (RR = 0.69, 95% CI: 0.59-0.82, P <0.05; RR = 0.84, 95% CI: 0.72-0.98, P = 0.03, respectively). With regard to safety, dual therapy had a higher risk of bleeding than monotherapy for both periods (RR = 1.51, 95% CI: 1.03-2.23, P = 0.04; RR = 1.54, 95% CI: 1.32-1.79, P<0.05, respectively).

CONCLUSIONS

Dual therapy with clopidogrel and aspirin could be a preferable choice to prevent stroke in patients who have had a previous stroke or transient ischemic attack, as well as those who are at high risk for stroke. And the effect of dual therapy seems to be more obvious for short-term. However, it is associated with a higher risk of bleeding.

Для цитирования: Tan Shuai, Xiao Xiaojuan, Ma Hanyu, Zhang Zhaohui, Chen Jiangbo, Ding Lei, Yu Shenping, Xu Rulin, Yang Shiliang, Huang Xinyi, Hong Hua. Clopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-Analysis.. PloS one. 2015. DOI: 10.1371/journal.pone.0135372.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.